Latest Boardroom Shifts News

Novatti has swung to a positive EBITDA of $2.0 million in FY26, driven by strategic refocusing on its core Payments AU/NZ business despite a 40.7% revenue decline and loss of control over AUDC.

MyEco Group has trimmed its net loss by 8.1% in FY26, driven by a strategic shift toward higher-margin sustainable consumer products and operational cost savings. Australian retail sales surged 22.7%, underpinning a stronger revenue mix and improved cash flow.

Praemium Limited reported a 5.7% revenue increase to $110.5 million and a 21.1% jump in funds under administration to $77.9 billion for FY26, driven by strong high-net-worth segment growth and the integration of OneVue. The acquisition of Technotia Laboratories and a major technology restructure signal a sharpened focus on innovation and cost efficiency.

Argent Minerals has secured regulatory approval to launch its first-ever drilling program at the Trunkey Creek Gold Project in NSW, targeting a 4.7km high-grade gold corridor. The initial 1,000m Phase 1 campaign aims to test priority underground targets beneath historic workings.

Encounter Resources has appointed Simon Hay as Non-Executive Chairman and promoted Will Robinson to Managing Director/CEO, aligning leadership with its expanding niobium and copper-gold projects. The company’s Aileron niobium resource surged 54% in 2026, underpinning development ambitions.

Michael Hill International delivered a landmark FY26 with record revenue of AU$655.7 million, a 57% jump in comparable EBIT, and reinstated dividends after a strategic turnaround.

Michael Hill International reported a 1.9% revenue increase to $655.7 million in FY26, with comparable EBIT up 57% to $24 million and net profit soaring 376%. The company restored dividends and announced a Chair succession.

Alterity Therapeutics posted a 285% jump in revenue to A$1.72 million but also a 93% rise in net loss to A$23.4 million for FY2026. The company secured FDA alignment on a single pivotal Phase 3 trial for ATH434 in Multiple System Atrophy, setting the stage for trial start by year-end.

Tartana Minerals has lodged a cleansing prospectus to enable ASX quotation of over 129 million options linked to a $4.5 million placement, with exercise price set at 5.5 cents and expiry in April 2029.

RooLife Group (ASX: RLG) reported a 268% jump in FY2026 revenue to nearly $10 million, driven by rapid growth in its own food and beverage products, including RLG Coffee in China. Despite this, the company recorded a $3.58 million net loss, weighed down by impairment charges and R&D investments in renewable energy.

HITIQ Limited posted a 21% drop in revenue to $1.59 million and reduced its net loss by 15% to $6.1 million for FY26, advancing commercialisation of its concussion management platform PROTEQT™ despite ongoing funding pressures and regulatory hurdles.

Mirrabooka Investments posted a 63.6% profit increase to $13 million for FY26 but saw its portfolio return lag the benchmark. The company declared a 14 cents fully franked dividend and welcomed Alison Gibson as new CEO following Mark Freeman's retirement.